Fed. Circ. Unsure Vanda's Sleep Med Hetlioz Is Patentable

Fed. Circ. Unsure Vanda’s Sleep Med Hetlioz Is Patentable

Časovni žig: 14. marec 2023 2:17
Izvorno vozlišče: 2009964
By Katie Buehler (March 14, 2023, 6:17 PM EDT) — A Federal Circuit panel seemed wary Tuesday of Vanda Pharmaceuticals’ attempt to overturn a Delaware federal judge’s decision invalidating four patents related to its sleep disorder treatment drug Hetlioz, questioning whether the drug’s dosage and method of administration were obvious before the patents were issued….

Časovni žig:

Več od Zakon 360